我院劉剛教授及其合作者近期在Journal of Medicinal Chemistry在線連續(xù)發(fā)表了兩篇研究性論文。第一篇是將有機化學方法學Late-Stage Functionalization應用于藥物化學的研究中,通過后期的化學修飾發(fā)現(xiàn)了一類新型P-糖蛋白抑制劑。后一篇內(nèi)容是通過限定小分子的構(gòu)象發(fā)現(xiàn)了新一類HBV殼組裝抑制劑,其前藥可以通過口服在小鼠體內(nèi)有效地抑制HBV復制。
?
題目1:Discovery of Potent Inhibitors against P?Glycoprotein-Mediated Multidrug Resistance Aided by Late-Stage Functionalization of a 2?(4-(Pyridin-2-yl)phenoxy)pyridine Analogue
作者: Yao Ma
# Dawei Yin
# Jingjia Ye
# Xiduan Wei, Yameng Pei, Xueyuan Li, Guangxu Si, Xuan-Yu Chen, Zhe-Sheng Chen, Yi Dong, Feng Zou, Wei Shi, Qianqian Qiu, Hai Qian,* and Gang Liu*(
https://dx.doi.org/10.1021/acs.jmedchem.0c00337)
?
題目2:Discovery of (1
H-Pyrazolo[3,4-c]pyridin-5-yl)sulfonamide Analogs as Hepatitis B Virus Capsid Assembly Modulators by Conformation Constraint
作者:Chunting Wang
#, Yameng Pei
#, Lin Wang, Shuo Li, Chao Jiang, Xu Tan, Yi Dong, Ye Xiang
*, Yao Ma
*, Gang Liu
* (
https://doi.org/10.1021/acs.jmedchem.0c00292)
版權(quán)與免責聲明:本網(wǎng)頁的內(nèi)容由收集互聯(lián)網(wǎng)上公開發(fā)布的信息整理獲得。目的在于傳遞信息及分享,并不意味著贊同其觀點或證實其真實性,也不構(gòu)成其他建議。僅提供交流平臺,不為其版權(quán)負責。如涉及侵權(quán),請聯(lián)系我們及時修改或刪除。郵箱:sales@allpeptide.com